Close Menu

NEW YORK (GenomeWeb) – Veracyte has filed with the US Securities and Exchange Commission for a proposed public offering of 5 million shares of its common stock, the firm said after the close of the market on Wednesday.

The genomic testing company also expects to grant the underwriters a 30-day option to purchase up to 750,000 additional shares at the public offering price.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.